iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
62 hedge funds and large institutions have $45.1M invested in iShares Genomics Immunology and Healthcare ETF in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 63 → 62 (-1)
Holders
62
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.03M | |
| 3 | +$498K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$408K |
| 5 |
Morgan Stanley
New York
|
+$385K |
Top Sellers
| 1 | -$882K | |
| 2 | -$465K | |
| 3 | -$386K | |
| 4 |
PI
PFG Investments
Woodbury,
New York
|
-$357K |
| 5 |
NSAM
North Star Asset Management
Neenah,
Wisconsin
|
-$267K |